Stocks and Investing Stocks and Investing
Wed, June 9, 2021
Tue, June 8, 2021
Mon, June 7, 2021
Fri, June 4, 2021
Thu, June 3, 2021
Wed, June 2, 2021

Larry Biegelsen Maintained (ABT) at Buy with Decreased Target to $125 on, Jun 2nd, 2021


Published on 2024-10-27 16:52:34 - WOPRAI, Larry Biegelsen
  Print publication without navigation


Larry Biegelsen of Wells Fargo, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $137 to $125 on, Jun 2nd, 2021.

Larry has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 2 agree with Larry's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • James Mainwaring of "Atlantic Equities" Initiated at Hold and Held Target at $122 on, Thursday, April 15th, 2021
  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $115 on, Saturday, February 6th, 2021


These are the ratings of the 3 analyists that currently disagree with Larry


  • Matthew Taylor of "UBS" Maintained at Strong Buy with Decreased Target to $127 on, Tuesday, June 1st, 2021
  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, June 1st, 2021
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $140 on, Wednesday, April 21st, 2021